- Home
- INBX vs LANV Comparison
INBX vs LANV Comparison
Compare INBX & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- LANV
- Stock Information
- Founded
- INBX 2010
- LANV 2015
- Country
- INBX United States
- LANV China
- Employees
- INBX N/A
- LANV N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- LANV Blank Checks
- Sector
- INBX Health Care
- LANV Finance
- Exchange
- INBX Nasdaq
- LANV Nasdaq
- Market Cap
- INBX 218.9M
- LANV 219.4M
- IPO Year
- INBX 2020
- LANV N/A
- Fundamental
- Price
- INBX $14.19
- LANV $2.30
- Analyst Decision
- INBX Hold
- LANV
- Analyst Count
- INBX 1
- LANV 0
- Target Price
- INBX N/A
- LANV N/A
- AVG Volume (30 Days)
- INBX 80.6K
- LANV 65.3K
- Earning Date
- INBX 11-14-2024
- LANV 02-19-2025
- Dividend Yield
- INBX N/A
- LANV N/A
- EPS Growth
- INBX N/A
- LANV N/A
- EPS
- INBX 119.38
- LANV N/A
- Revenue
- INBX $1,568,000.00
- LANV $409,961,427.00
- Revenue This Year
- INBX N/A
- LANV N/A
- Revenue Next Year
- INBX N/A
- LANV $10.45
- P/E Ratio
- INBX $0.11
- LANV N/A
- Revenue Growth
- INBX 19.24
- LANV N/A
- 52 Week Low
- INBX $10.80
- LANV $0.91
- 52 Week High
- INBX $18.95
- LANV $3.78
- Technical
- Relative Strength Index (RSI)
- INBX 47.10
- LANV 63.91
- Support Level
- INBX $12.51
- LANV $1.38
- Resistance Level
- INBX $14.86
- LANV $2.04
- Average True Range (ATR)
- INBX 1.05
- LANV 0.29
- MACD
- INBX -0.14
- LANV 0.01
- Stochastic Oscillator
- INBX 38.89
- LANV 85.70
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.